Thyroid cancer follow-up reminders for low-risk patients
Part of Cancer, Hormones & metabolism clinical trials.
This study tests a smartphone-based reminder system to help people with earlier-stage differentiated thyroid cancer stay on track for follow-up visits and testing. It may help catch problems sooner and make follow-up easier to manage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 and able to consent to take part
- You have thyroid cancer classified as low-risk stage 1, or stage 2 (and both have no signs of return on scans and blood tests)
- Your most recent treatment was at least 24 months ago for stage 1, or at least 48 months ago for stage 2
- Your blood tests are reassuring: very low thyroid tumor marker (hsTG) and low anti-thyroglobulin antibodies (anti-TG AB) and your thyroid ultrasound shows no regional recurrence
- You have a primary care doctor (PCP) you have consented/registered with
- You can use a mobile app (Medable or your own phone) and have internet access
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether it is safe to monitor small, low-risk thyroid cancers (1–4 cm) instead of removing the remaining thyroid tissue after initial surgery. It may help you avoid a second operation and lifelong medication if your cancer is truly low-risk.
This trial tests whether it is safe to avoid immediate surgery and instead monitor small thyroid cancers that are considered low-risk. If you join, doctors will check regularly to make sure the cancer does not grow or spread.
This study tests whether a structured online follow-up program helps patients recover better after thyroid surgery. You'll use your smartphone to check in with your care team instead of always coming to the hospital.
This trial tests whether online follow-up visits work well for people with papillary thyroid cancer after surgery. If you are comfortable using a smartphone or computer to check in with your doctor, this study might be a good fit.
This study follows adults who have medullary thyroid cancer (MTC) to learn how the cancer behaves over time. It may help by improving future care and follow-up strategies for people with MTC.
This trial tests whether an online educational program, completed before your first clinic visit, helps you better understand your thyroid cancer diagnosis and treatment options. It is designed for people with small thyroid nodules that are likely or confirmed to be a common type of thyroid cancer.
Hear when a new Low Risk Differentiated Thyroid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.